Fig. 6From: Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stageOS and DFS of XELOX and S-1 within N3. (A) LNR1,2 within N3. (B) LNR3 within N3. XELOX regimen showed significantly better efficacy compared to S-1 in LNR3 within N3, but not in LNR1,2 within N3Back to article page